SciELO - Scientific Electronic Library Online

 
vol.33 issue3Silicone coated thermoplastic mask for management of hypertrophic facial scarsSpinal tuberculosis with pleural involvement: a case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Medicas UIS

Print version ISSN 0121-0319On-line version ISSN 1794-5240

Abstract

ZAMBRANO URBANO, Jose Leonel; OCAMPO CHAPARRO, José Mauricio; LERMA FLORES, Eduardo  and  CASANOVA, María Eugenia. Serotonin syndrome as an infrequent adverse reaction to synergy between Linezolid and Fentanyl: case presentation. Medicas UIS [online]. 2020, vol.33, n.3, pp.59-66.  Epub Oct 30, 2020. ISSN 0121-0319.  https://doi.org/10.18273/revmed.v33n3-2020007.

Serotonin syndrome is a life-threatening condition caused by medications that affect serotonin metabolism or that act as direct agonists for serotonin receptor or a combination of both. The syndrome gives rise to a variety of mental, autonomic, and neuromuscular manifestations, which can range from mild to life-threatening. We report a clinical case of a patient who developed this syndrome due to the co-administration and synergism of linezolid and fentanyl, with a wide variety of clinical characteristics, from the most subtle, such as high blood pressure levels difficult to manage while under the effect of sedoanalgesia, to the most florid manifestations of the syndrome after 48 hours of its suspension. The association of these drugs represents a poorly reported etiology that may favor the appearance of the syndrome, while the use of benzodiazepines may mask the condition, making its diagnosis difficult. MÉD.UIS.2020;33(3): 59-66

Keywords : Serotonin syndrome; Linezolid; Fentanyl.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )